Bone Loss: Clinical Trials

2 trials for Bone Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 31Terminated 1

Follow Bone Loss: new trials by email Literature Review of Bone Loss trials Research Report on Bone Loss

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bone in CKD Alkali Response (BICARb Pilot Trial)
Potassium Citrate Extended Release Oral Tablet, Placebo, Potassium Citrate and Citric Acid Oral Solution - Chronic Kidney Diseases, Bone Loss
Phase 2 / Phase 3TerminatedAlbert Einstein College of Medicine62024-08-152026-07-28
Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
zoledronic acid, placebo - Bone Loss
Phase 2TerminatedThomas J. Schnitzer172010-03-012017-06-14

Narrower conditions

Bone Diseases, Metabolic (2)  ·  Acidosis (1)  ·  Fractures, Bone (1)  ·  Osteoporosis (1)  ·  Renal Insufficiency, Chronic (1)  ·  Spinal Cord Injuries (1)

Broader conditions

Bone Diseases (2)  ·  Metabolic Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Wounds and Injuries (2)  ·  Acid-Base Imbalance (1)  ·  Central Nervous System Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)

Interventions

Citric Acid (1)  ·  Potassium Citrate (1)  ·  Zoledronic Acid (1)

Sponsors

Albert Einstein College of Medicine (1)  ·  Thomas J. Schnitzer (1)

Countries

United States (2)

Top investigators

Kimberly Reidy, MD (1)  ·  Thomas J Schnitzer, MD, PhD (1)

Results publications

PMID 26828618, PMID 39665575

NIH funding

2023 (1), R01DK131811 (1)